Use access key #2 to skip to page content.
$50.85 -0.06 (-0.12%)
5/12/2008 4:01 PM

Novartis AG (ADR) (NVS)

CAPS Rating:
*****

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating NVS

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

763 Outperforms
30 Underperforms
 

All-Stars

243 Outperforms
7 Underperforms
 

Wall Street

13 Outperforms
2 Underperforms
 

Players bullish on NVS are also bullish on:

Players bearish on NVS are also bearish on:

Ticker Tags

Bird Flu (8), Big Pharma (12), Drug Manufacturers - Major (27), Mega Cap (146), Top Brands 2005 (65), Switzerland (11), Top Brands 2006 (64)
Suggest a tag

Novartis AG (ADR) At A Glance

Current Price: $50.85
Last Trade Time: 5/12/2008 4:01 PM
Open: $50.91
Previous Close: $50.91
Daily Range: $49.76 - $51.04
52-Week Range: $46.19 - $59.17
Volume: 1,558,094
Market Cap: $138.93B
P/E Ratio: 18.12
Compare Our Special Broker Offers!

Stock Trends

NVS VS S&P 500 (SPY)

NVS 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

1

Novartis AG (ADR) (NVS)

Avatar xthecritic (69.20) Submitted: 4/23/08 8:59 AM

Ask CAPS to stop censoring user blogs.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

4

Novartis AG (ADR) (NVS)

Avatar interactdv (< 20) Submitted: 4/06/07 12:45 AM

Zelnorm recall will result in a flurry of class action suits (as palgued Vioxx). While most will be deemed without merit there will be a flood of litigants eager to latch on to some of the extra cash that Novartis has at hand.
Long-term Novartis has an excellent arsenal of drugs and developmen...More

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 124 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (NVS)

Avatar JustWokeUp (42.77) Submitted: 5/04/08 1:38 AM : Outperform Start Price: $50.94 NVS Score: 0.24

Great fundamental... Great Technical... What else is there to worry about?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVS)

Avatar deuspecuniae (< 20) Submitted: 5/01/08 12:11 PM : Outperform Start Price: $50.03 NVS Score: 1.02

The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVS)

Avatar Smiley81 (74.86) Submitted: 4/29/08 10:52 AM : Outperform Start Price: $50.50 NVS Score: -0.12

$60+/share

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVS)

Avatar wallemonster (55.96) Submitted: 4/28/08 1:01 AM : Outperform Start Price: $50.19 NVS Score: 0.86

It's Switz - I wanted to give it a neutral..

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVS)

Avatar susann55 (24.66) Submitted: 4/24/08 7:54 PM : Underperform Start Price: $50.99 NVS Score: 1.03

Been in the market for some time and shows growth potential, but with current conditions I see them lacking growth.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 124 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 15 of 15  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBernstein 66.74 05/09/08 Outperform NS $50.97-0.24%+1.49%-1.72
TrackHSBC 93.94 02/29/08 Underperform NS $50.11+1.48%+3.58%+2.11
TrackTobinSmith < 20 01/25/08 Outperform 1Y $48.80+4.21%+5.58%-1.37
TrackPatDorsey 75.43 11/09/07 Outperform 5Y $50.60+0.49%-3.22%+3.71
TrackEveillard 86.50 09/30/07 Outperform NS $53.38-4.74%-7.94%+3.20 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 71.22 09/30/07 Outperform NS $53.38-4.74%-7.94%+3.20 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 93.10 09/30/07 Outperform NS $53.38-4.74%-7.94%+3.20 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley 94.97 09/30/07 Outperform NS $53.38-4.74%-7.94%+3.20 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $53.38-4.74%-7.94%+3.20 Toggle the visibility of 60-Second Pitch and replies
TrackUBS 93.95 09/06/07 Outperform NS $51.85-1.92%-5.06%+3.14
TrackCreditSuiss 94.99 07/18/07 Underperform NS $51.95-2.12%-8.93%-6.81
TrackJimJubak 92.37 12/01/06 Outperform 1Y $55.11-7.73%+0.23%-7.96
TrackPrudential 84.40 10/20/06 Outperform NS $57.52-11.59%+2.59%-14.18
TrackBofASec 94.03 09/11/06 Outperform NS $53.78-5.45%+8.16%-13.62
TrackJimCramer 81.00 03/29/06 Outperform 3W $52.58-3.29%+7.73%-11.03

Results 1 - 15 of 15  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners